Preparation and in vitro/in vivo evaluation of microparticle formulations containing meloxicam

AAPS PharmSciTech

Volumn 13, Issue 1, 2012, Pages 46-52

  Eroglu, Hakan ^a   Burul Bozkurt, Nihan ^a   Uma, Serdar ^a   Oner, Levent ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chitosan; In vitro in vivo correlation; Meloxicam; Microparticle; Sodium alginate

Indexed keywords

ALGINIC ACID; CHITOSAN; MELOXICAM;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COATING; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG RETENTION; EXPERIMENTAL RABBIT; GELATION; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; SURFACE PROPERTY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DRUG EVALUATION, PRECLINICAL; MICROSPHERES; RABBITS; THIAZINES; THIAZOLES;

EID: 84861096701     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9718-7     Document Type: Article

References (26)

1. Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clin Pharmacokinet. 1999;36(2):115-26. (Pubitemid 29121685)
2. Chiou AHJ, Yeh MK, Chen CY, Wang DP. Micronization of meloxicam using a supercritical fluids process. J Supercrit Fluids. 2007;42(1):120-8.
3. Luger P, Daneck K, Engel W, Trummlitz G, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci. 1996;4(3):175-87. (Pubitemid 26174671)
4. Sanford P. Chitosan: commercial uses and potential applications. In: Skjak-Braek G, Anthonsen T, Sanford P, editors. Chitin and chitosan. London: Elsevier Applied Science; 1988. p. 51-69.
5. Chaubal M. Using chitosan as an excipient for oral delivery. Drug Delivery Tech. 2008;3(3). http://www.drugdeliverytech.com/cgi-bin/articles.cgi? idArticle=131
6. Peniche C, Arguelles-Monal W, Peniche H, Acosta N. Chitosan: an attractive biocompatible polymer for microencapsulation. Macromol Biosci. 2003;3(10):511-20. (Pubitemid 37309674)
7. CDER. Guidance for industry: extended release oral dosage forms: development and application of in vitro/in vivo correlations. Silver Spring: CDER; 1997.
8. Sunesen VH, Pedersen BL, Kristensen HG, Mullertz A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur J Pharm Sci. 2005;24(4):305-13. (Pubitemid 40283513)
9. Takka S, Sakr A, Goldberg A. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. J Control Release. 2003;88(1):147-57. (Pubitemid 36173960)
10. Modi NB, Lam A, Lindemulder E, Wang B, Gupta SK. Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications. Biopharm Drug Dispos. 2000;21(8):321-6. (Pubitemid 32780847)
11. Kortejarvi H, Mikkola J, Backman M, Antila S, Marvola M. Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules. Int J Pharm. 2002;241 (1):87-95. (Pubitemid 34667069)
12. Dutta S, Qiu Y, Samara E, Cao G, Granneman GR. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a level A in vitro-in vivo correlation (IVIVC). J Pharm Sci. 2005;94(9):1949-56. (Pubitemid 41551479)
13. Ghosh A, Bhaumik UK, Bose A, Mandal U, Gowda V, Chatterjee B, et al. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation. Biol Pharm Bull. 2008;31(10):1946-51.
14. Mandal U, Ray KK, Gowda V, Ghosh A, Pal TK. In-vitro and invivo correlation for two gliclazide extended-release tablets. J Pharm Pharmacol. 2007;59(7):971-6. (Pubitemid 47051078)
15. Balan G, Timmins P, Greene DS, Marathe PH. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. J Pharm Sci. 2001;90(8):1176-85.
16. Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm. 2002;232(1-2):225-34. (Pubitemid 34076768)
17. Dülger B, Nemutlu E, Sayin F, Basçi N and Kir S. Capillary and high performance liquid chromatography determination of meloxicam tablets. In: 3rd Aegean Analytical Chemistry Days. Lesvos, Greece; 2002.
18. Velpandian T, Jaiswal J, Bhardwaj RK, Gupta SK. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. J Chromatogr B Biomed Sci Appl. 2000;738(2):431-6. (Pubitemid 30089470)
19. Moore J, Flanner H. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20:64-74. (Pubitemid 126450495)
20. CDER. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Silver Spring: CDER; 1997.
21. Wagner JG. Biopharmaceutics and relevant pharmacokinetics. Hamilton: Drug Intelligence; 1981.
22. Eddington ND, Marroum P, Uppoor R, Hussain A, Augsburger L. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation. Pharm Res. 1998;15(3):466-73. (Pubitemid 28175130)
23. Eroglu H, Burul-Bozkurt N, Uma S, Oner L. Validation of the analytical method for in-vivo determination of meloxicam and bioequivalence study from meloxicam containing microparticle formulations in rabbits. Hacettepe University J Fac Pharm. 2009;29(2):115-30.
24. Kumbar SG, Kulkarni AR, Aminabhavi M. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. J Microencapsul. 2002;19(2):173-80. (Pubitemid 34100610)
25. Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm. 2003;29(6):713-24. (Pubitemid 36835163)
26. Xu Y, Zhan C, Fan L, Wang L, Zheng H. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm. 2007;336(2):329-37. (Pubitemid 46670661)